Last Updated on July 13, 2021 by The Health Master
These formulations are as under:
|Sl. No.||Name of the Formulation / Brand Name||Strength||Unit||Manufacturer & Marketing Company||Retail Price (Rs.)|
|1.||Telmisartan + Nebivolol Tablet||Each uncoated Bilayered Tablet Contains: Telmisartan IP 40 mg Nebivolol Hydrochloride IP Equivalent to Nebivolol 5 mg||1 Tablet||M/s Eris Lifesciences Limited||13.61|
|2.||Glimeperide + Pioglitazone + Metformin HCL (SR) Tablet||Each uncoated bilayered tablet contains: Glimeperide IP 2mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 1000mg (in sustained release form)||1 Tablet||M/s Windlas Biotech Pvt. Ltd. / M/s Eris Lifesciences Limited||12.85|
|3.||Glimeperide + Pioglitazone + Metformin HCL (SR) Tablet||Each uncoated bilayered tablet contains: Glimeperide IP 1mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15mg Metformin Hydrochloride IP 1000mg (in sustained release form)||1 Tablet||M/s Windlas Biotech Pvt. Ltd. / M/s Eris Lifesciences Limited||8.73|
|4.||Glimeperide + Metformin HCL (SR) Tablet||Each uncoated tablet contains: Glimeperide IP 2mg Metformin Hydrochloride IP 1000mg (in sustained release form)||1 Tablet||M/s M/s Agron Remedies Private Limited / M/s Cadila Pharmaceuticals Ltd.||9.44|
|5.||Glimeperide + Metformin HCL (SR) Tablet||Each uncoated tablet contains: Glimeperide IP 1mg Metformin Hydrochloride IP 1000mg (in sustained release form)||1 Tablet||M/s M/s Agron Remedies Private Limited / M/s Cadila Pharmaceuticals Ltd.||6.86|
|6.||Dextromethorphan Hydrobromide + Chlorpheniramine Meleate Syrup||Each 5ml contains: Dextromethorphan Hydrobromide IP 10mg Chlorpheniramine Meleate IP 2mg||1 ML||M/s East African (India) Overseas / M/s Cadila Pharmaceuticals Ltd.||0.64|
|7.||Esomeprazole & Domperidone sustained release capsule||Each hard gelatine capsule contains: Esomeprazole Magnesium IP eq. to Esomeprazole 40mg (as enteric coated pellets), Domperidone IP 30mg (as sustained release pellets)||1 Capsul e||M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Jagsonpal Pharmaceuticals Ltd.||10.20|
|8.||Telmisartan + Amlodipine + Hydrochlorathiazide Tablet||Each film coated tablet contains: Telmisartan IP 40mg, Amlodipine Besylate IP eq. to Amlodipine 5mg, Hydrochlorothiazide IP 12.50 mg||1 Tablet||M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cadila Pharmaceuticals Ltd.||9.56|
|9.||Nebivolol Hydrochloride + Telmisartan Tablet||Each uncoated bilayered tablet contains: Nebivolol Hydrochloride IP eq. to Nebivolol 5mg Telmisartan IP 40mg||1 Tablet||M/s Windlas Biotech limited / M/s Eris Lifesciences Limited||13.61|
|10.||Vitamin D3 Oral Drops||Each ml contains: Cholecalciferol (Vitamin D3) IP 800IU||1 ML||M/s Akums Drugs & Pharmaceuticals Limited / M/s Cipla Limited||5.06|
|11.||Paracetamol + Methocarbamol + Diclofenac Potassium tablet||Each Film coated tablet contains: Paracetamol IP 325mg Methocarbamol IP 500mg Diclofenac Potassium BP 50mg tablet||1 Tablet||M/s Shiv Industries / M/s Profic Organic Limited||7.96|
The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a Price List in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
As per para 24(4) of DPCO 2013, every retailer and dealer shall display Price List and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
For informative videos by The Health Master, click on the below YouTube icon: